BeiGene, Ltd. (BGNE)
USD 184.71
(0.49%)
USD 184.71
(0.49%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.25 Billion USD | 24.35% |
| 2022 | -2.97 Billion USD | 19.09% |
| 2021 | -3.68 Billion USD | -348.91% |
| 2020 | -819.98 Million USD | -140.7% |
| 2019 | -340.66 Million USD | 33.79% |
| 2018 | -514.53 Million USD | -587.08% |
| 2017 | -74.88 Million USD | -6.63% |
| 2016 | -70.23 Million USD | -2507.61% |
| 2015 | 2.91 Million USD | 4961.67% |
| 2014 | -60 Thousand USD | -100.26% |
| 2013 | 23.43 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -1.52 Billion USD | 11.55% |
| 2024 Q1 | -1.69 Billion USD | 24.6% |
| 2023 Q3 | -2.48 Billion USD | 8.97% |
| 2023 Q4 | -2.25 Billion USD | 9.43% |
| 2023 FY | -2.25 Billion USD | 24.35% |
| 2023 Q1 | -2.99 Billion USD | -0.5% |
| 2023 Q2 | -2.73 Billion USD | 8.72% |
| 2022 Q3 | -3.48 Billion USD | 10.57% |
| 2022 Q2 | -3.89 Billion USD | -6.07% |
| 2022 Q1 | -3.67 Billion USD | 0.16% |
| 2022 FY | -2.97 Billion USD | 19.09% |
| 2022 Q4 | -2.97 Billion USD | 14.57% |
| 2021 Q2 | -1.09 Billion USD | 13.23% |
| 2021 Q4 | -3.68 Billion USD | -438.34% |
| 2021 FY | -3.68 Billion USD | -348.91% |
| 2021 Q1 | -1.26 Billion USD | -54.05% |
| 2021 Q3 | -683.77 Million USD | 37.62% |
| 2020 Q1 | -1.65 Billion USD | -387.0% |
| 2020 FY | -819.98 Million USD | -140.7% |
| 2020 Q4 | -819.98 Million USD | 32.83% |
| 2020 Q3 | -1.22 Billion USD | -24.15% |
| 2020 Q2 | -983.24 Million USD | 40.73% |
| 2019 Q3 | -570.94 Million USD | 11.29% |
| 2019 Q4 | -340.66 Million USD | 40.33% |
| 2019 FY | -340.66 Million USD | 33.79% |
| 2019 Q1 | -493.9 Million USD | 4.01% |
| 2019 Q2 | -643.56 Million USD | -30.3% |
| 2018 Q1 | -316.95 Million USD | -323.24% |
| 2018 FY | -514.53 Million USD | -587.08% |
| 2018 Q4 | -514.53 Million USD | -14.98% |
| 2018 Q3 | -447.51 Million USD | -95.7% |
| 2018 Q2 | -228.66 Million USD | 27.85% |
| 2017 Q3 | -50.16 Million USD | 53.67% |
| 2017 Q1 | -77.84 Million USD | -10.84% |
| 2017 FY | -74.88 Million USD | -6.63% |
| 2017 Q4 | -74.88 Million USD | -49.29% |
| 2017 Q2 | -108.27 Million USD | -39.09% |
| 2016 FY | -70.23 Million USD | -2507.61% |
| 2016 Q4 | -70.23 Million USD | -4.04% |
| 2016 Q2 | -47.53 Million USD | 76.5% |
| 2016 Q1 | -202.29 Million USD | -7034.93% |
| 2016 Q3 | -67.5 Million USD | -42.02% |
| 2015 Q4 | 2.91 Million USD | 142.76% |
| 2015 Q2 | -11.1 Million USD | -125.02% |
| 2015 FY | 2.91 Million USD | 4961.67% |
| 2015 Q1 | 44.39 Million USD | 74091.67% |
| 2015 Q3 | -6.82 Million USD | 38.59% |
| 2014 Q4 | -60 Thousand USD | 0.0% |
| 2014 FY | -60 Thousand USD | -100.26% |
| 2013 FY | 23.43 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -3927.687% |
| Alkermes plc | -166.73 Million USD | -1251.266% |
| Agenus Inc. | 274.13 Million USD | 921.887% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 220.49% |
| Aptorum Group Limited | 1.35 Million USD | 166128.86% |
| Ardelyx, Inc. | 34.51 Million USD | 6628.419% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 52742.243% |
| Bicycle Therapeutics plc | -481.46 Million USD | -367.963% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 6330.368% |
| ChromaDex Corporation | -24.04 Million USD | -9269.128% |
| Chimerix, Inc. | -25.51 Million USD | -8729.753% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 32434.435% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -9415.935% |
| CRISPR Therapeutics AG | -150.84 Million USD | -1393.644% |
| Precision BioSciences, Inc. | -85.41 Million USD | -2537.967% |
| Dyadic International, Inc. | -6.37 Million USD | -35225.385% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -14041.016% |
| Fortress Biotech, Inc. | 7.66 Million USD | 29494.494% |
| Lantern Pharma Inc. | -21.7 Million USD | -10281.326% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -1938.311% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -26272.955% |
| Incyte Corporation | -3.17 Billion USD | 29.039% |
| IO Biotech, Inc. | -140.69 Million USD | -1501.353% |
| Jaguar Health, Inc. | 29.39 Million USD | 7765.911% |
| Novavax, Inc. | -298.29 Million USD | -655.325% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 42316.376% |
| Opthea Limited | 28.15 Million USD | 8101.749% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -13320.025% |
| ContextLogic Inc. | -232 Million USD | -871.159% |
| MiMedx Group, Inc. | -33.9 Million USD | -6546.081% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 22199.931% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -97140.472% |
| NextCure, Inc. | -6.47 Million USD | -34685.981% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -4361.472% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -35220.395% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 18623.707% |
| Vaxcyte, Inc. | -368.22 Million USD | -511.875% |
| PDS Biotechnology Corporation | -32.7 Million USD | -6788.303% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 13140.213% |
| Pharming Group N.V. | 109.8 Million USD | 2151.918% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -12851.759% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -1185.789% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -12065.797% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -12065.797% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -31633.634% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -38348.601% |
| Acelyrin, Inc. | -216.9 Million USD | -938.754% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -40060.085% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -130589.559% |
| Summit Therapeutics Inc. | 34.67 Million USD | 6597.918% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -33019.036% |
| Senti Biosciences, Inc. | 1.74 Million USD | 129587.816% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -1120.478% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -2809.05% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -37067.403% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 2258404.684% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 358871.975% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -1824.959% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -1239.266% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 2132.189% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -29561.506% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -1645.038% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 32779.034% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -829.634% |
| Immix Biopharma, Inc. | -17.5 Million USD | -12767.589% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -611.42% |
| MEI Pharma, Inc. | -3.7 Million USD | -60712.092% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 18108.856% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 1493.014% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 8206.674% |
| Fortress Biotech, Inc. | 7.66 Million USD | 29494.494% |
| Precigen, Inc. | -481 Thousand USD | -468317.464% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 16100.909% |
| AlloVir, Inc. | -62.69 Million USD | -3493.9% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -3951.296% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 3753.696% |
| ImmuCell Corporation | 10.99 Million USD | 20600.207% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -1361.658% |
| Onconetix, Inc. | 5.33 Million USD | 42360.426% |
| PureTech Health plc | -167.19 Million USD | -1247.565% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -7296.875% |
| Elevation Oncology, Inc. | -19.11 Million USD | -11685.166% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -45797.087% |
| Seer, Inc. | -4.24 Million USD | -53038.868% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -9273.416% |
| Innoviva, Inc. | 255.56 Million USD | 981.617% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -3933.166% |
| ESSA Pharma Inc. | -33.62 Million USD | -6601.314% |
| GlycoMimetics, Inc. | -40.98 Million USD | -5397.425% |
| GT Biopharma, Inc. | -1.02 Million USD | -220574.633% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -3223.972% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 3778.091% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -1580.418% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -16160.739% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -7703.713% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -2990698.312% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -7200.525% |
| Aptose Biosciences Inc. | -8.19 Million USD | -27393.927% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -71906.233% |
| Soligenix, Inc. | -4.95 Million USD | -45402.249% |
| Century Therapeutics, Inc. | 847 Thousand USD | 266108.028% |
| Kura Oncology, Inc. | -20.11 Million USD | -11099.364% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -5405.273% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -26728.864% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 123780.858% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -70375.07% |
| Autolus Therapeutics plc | -186.59 Million USD | -1107.449% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -4469.787% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -716.946% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 6674.904% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 1470.758% |
| GRI Bio, Inc. | -1.79 Million USD | -125490.19% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -24981.559% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -6674.778% |
| IGM Biosciences, Inc. | -72.6 Million USD | -3003.171% |
| INmune Bio, Inc. | -25.41 Million USD | -8766.585% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 1592.596% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -4347.557% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -13765.693% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -77998.641% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 6026.839% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -5370.652% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 7166.294% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 696.132% |
| Verastem, Inc. | -37.27 Million USD | -5944.015% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -24732.889% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -4244.391% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -14786.607% |
| Histogen Inc. | -7.48 Million USD | -29993.335% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -10327.671% |
| Surrozen, Inc. | -32.66 Million USD | -6797.771% |
| Organovo Holdings, Inc. | -1.5 Million USD | -149408.162% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -53500.438% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 11983.245% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 86227.217% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 54312.897% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -26782.802% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -5086.428% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -15356.607% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -611.227% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -311936.119% |
| Apollomics, Inc. | -27.39 Million USD | -8124.45% |
| Amarin Corporation plc | -191.04 Million USD | -1079.38% |
| Mesoblast Limited | 55.96 Million USD | 4126.031% |
| Turnstone Biologics Corp. | -14.58 Million USD | -15349.04% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -8808.303% |
| Synaptogenix, Inc. | -28.66 Million USD | -7761.027% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -240614.53% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 4723.426% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -261252.134% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -30908.302% |
| Exelixis, Inc. | -73.05 Million USD | -2984.309% |
| Better Therapeutics, Inc. | -860 Thousand USD | -261886.977% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -9282.784% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -833.454% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 306198.638% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -30191.034% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 179772.089% |
| Gritstone bio, Inc. | 39.49 Million USD | 5805.465% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -2579.026% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -85499.094% |
| Avid Bioservices, Inc. | 169.72 Million USD | 1427.47% |
| Insmed Incorporated | 721.62 Million USD | 412.226% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -24546.776% |
| MediWound Ltd. | -5.32 Million USD | -42235.363% |
| OmniAb, Inc. | 9.2 Million USD | 24582.104% |
| Alector, Inc. | -35.63 Million USD | -6222.328% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 2720.754% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -45620.13% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 17118.566% |
| Zai Lab Limited | -775 Million USD | -190.721% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 761.593% |
| Aura Biosciences, Inc. | -21.52 Million USD | -10367.308% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -2631.678% |
| Immunic, Inc. | -45.34 Million USD | -4869.316% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -1066.104% |
| Veracyte, Inc. | -203.82 Million USD | -1005.409% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 452.986% |
| FibroGen, Inc. | 56.76 Million USD | 4069.01% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 25401.381% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -79596.592% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -108726.535% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 149.083% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -67337.534% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -1257.576% |
| TG Therapeutics, Inc. | 17.86 Million USD | 12713.862% |
| Galecto, Inc. | -21.21 Million USD | -10519.759% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -9372.727% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 243.564% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -9106.8% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -19480.151% |
| XBiotech Inc. | -200.02 Million USD | -1026.414% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -2579.026% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 49859.011% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -6289.383% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -2817.827% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 39690.371% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -1222.118% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -2339.093% |
| Vaxxinity, Inc. | 10.13 Million USD | 22337.347% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 406.015% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -20824.795% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -3316.047% |
| NexImmune, Inc. | -3.13 Million USD | -71799.958% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -65156.339% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -14809.807% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -8213.978% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -25001.1% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -1808519.707% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -5453.308% |
| Ainos, Inc. | 4.07 Million USD | 55350.804% |
| Pluri Inc. | 22.82 Million USD | 9969.412% |
| Prothena Corporation plc | -608.34 Million USD | -270.362% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -1797.241% |
| Celularity Inc. | 65.19 Million USD | 3556.187% |
| Rallybio Corporation | -24.1 Million USD | -9248.137% |
| Cue Biopharma, Inc. | -33.81 Million USD | -6562.196% |
| MeiraGTx Holdings plc | -40.3 Million USD | -5490.512% |
| Omeros Corporation | 331.17 Million USD | 780.329% |
| Humacyte, Inc. | -22.48 Million USD | -9919.959% |
| Immunocore Holdings plc | -358.59 Million USD | -528.312% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -9068.212% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -7191.311% |
| Blueprint Medicines Corporation | 702.83 Million USD | 420.571% |
| CalciMedica, Inc. | -5.53 Million USD | -40643.002% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -1097.05% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -21958.821% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -5527.515% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -6675.593% |
| Pulmatrix, Inc. | -10.41 Million USD | -21528.953% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -37595.968% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -5807.105% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -1922.484% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -3658.654% |
| Cytokinetics, Incorporated | 642.37 Million USD | 450.745% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -38592.907% |
| Nutriband Inc. | -251.65 Thousand USD | -895201.144% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -6503.617% |
| Vor Biopharma Inc. | 4.3 Million USD | 52497.395% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 62.672% |
| Evogene Ltd. | -19.63 Million USD | -11375.441% |
| ProKidney Corp. | -56.23 Million USD | -3906.487% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -4529.126% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -24291.495% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 265.194% |
| CorMedix Inc. | -43.05 Million USD | -5133.349% |
| BioLineRx Ltd. | 7.33 Million USD | 30812.759% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -8103.488% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 4982.415% |
| Atai Life Sciences N.V. | -28.55 Million USD | -7789.516% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 101111.374% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -9775.035% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 12804.189% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -2901.156% |
| MediciNova, Inc. | -50.78 Million USD | -4336.652% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -2759.067% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -10015850.211% |
| GeoVax Labs, Inc. | -6.45 Million USD | -34817.581% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -1027.553% |
| Biomea Fusion, Inc. | -166.57 Million USD | -1252.637% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -1158.884% |
| Mereo BioPharma Group plc | -51.46 Million USD | -4277.563% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -2275.573% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -666.985% |
| Absci Corporation | -72.59 Million USD | -3003.512% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 49444.897% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -861.063% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -2291.534% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -2254.422% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -5666.355% |
| Allakos Inc. | -24.97 Million USD | -8921.373% |
| Imunon, Inc. | -4.21 Million USD | -53368.608% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -15183.462% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -1564.024% |
| BioAtla, Inc. | -109.01 Million USD | -1966.845% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 306198.638% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -239845.474% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 18929.082% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -10526.27% |
| XOMA Corporation | -29 Million USD | -7669.269% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -13505.604% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -24889.885% |
| aTyr Pharma, Inc. | -7.44 Million USD | -30146.852% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -1707.735% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -982.362% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -2655.094% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -2328.865% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -262135.796% |
| Akari Therapeutics, Plc | -3.84 Million USD | -58497.867% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 138931.837% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 263.163% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -189532.323% |
| UroGen Pharma Ltd. | 4.39 Million USD | 51411.501% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 2085.432% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 3131041.33% |
| Orgenesis Inc. | 21.78 Million USD | 10442.857% |
| Entera Bio Ltd. | -10.62 Million USD | -21097.554% |
| GH Research PLC | -78.07 Million USD | -2785.726% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -10008.973% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -8351.51% |
| Xencor, Inc. | 29.64 Million USD | 7700.486% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -114280.865% |
| Replimune Group, Inc. | 1.41 Million USD | 159667.139% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -919873.214% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -1682.267% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -189532.323% |
| Portage Biotech Inc. | -4.98 Million USD | -45133.648% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -10015850.211% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -3307.471% |
| OncoCyte Corporation | -6.56 Million USD | -34230.154% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 251164.783% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -49357.08% |
| Purple Biotech Ltd. | -14.13 Million USD | -15836.398% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -9384.29% |
| scPharmaceuticals Inc. | -6.54 Million USD | -34324.568% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -13397.878% |
| HilleVax, Inc. | -165.48 Million USD | -1261.506% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -88674.153% |
| Tharimmune, Inc. | -10.93 Million USD | -20503.708% |
| Genprex, Inc. | -6.73 Million USD | -33340.369% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -510.912% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -2447.013% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -160719.986% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -67826.581% |
| OKYO Pharma Limited | -826.84 Thousand USD | -272391.195% |
| Savara Inc. | 153 Thousand USD | 1472706.536% |
| Curis, Inc. | -23.88 Million USD | -9332.277% |
| Daré Bioscience, Inc. | -5.15 Million USD | -43582.181% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -290241.902% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -36193.299% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 190234.008% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 18360.631% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | -270.449% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -1114.04% |
| Erasca, Inc. | -37.21 Million USD | -5954.084% |
| bluebird bio, Inc. | 108.57 Million USD | 2175.221% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -174843.726% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 694.878% |
| DBV Technologies S.A. | -126.98 Million USD | -1674.281% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -174843.726% |
| Moderna, Inc. | -2.9 Billion USD | 22.494% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -21664.76% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -20631.395% |
| Molecular Templates, Inc. | 707 Thousand USD | 318782.885% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -7082.073% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 750.039% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -2645.592% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -2356.217% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -6881.557% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -6454.247% |
| MacroGenics, Inc. | -66.98 Million USD | -3263.571% |
| RenovoRx, Inc. | -1.17 Million USD | -191979.113% |
| Adicet Bio, Inc. | -138.78 Million USD | -1523.414% |
| Prime Medicine, Inc. | -27.94 Million USD | -7963.734% |
| Aditxt, Inc. | 18.12 Million USD | 12533.653% |
| Adagene Inc. | -87.62 Million USD | -2471.214% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -53990.192% |
| Quantum-Si incorporated | -118.55 Million USD | -1800.426% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 6357.709% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -30044.92% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -4544.68% |
| SciSparc Ltd. | -2.06 Million USD | -109008.378% |
| Vericel Corporation | 1.27 Million USD | 176536.022% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -18688.727% |
| Minerva Neurosciences, Inc. | 41 Million USD | 5594.767% |
| Generation Bio Co. | 31.44 Million USD | 7264.487% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -1184.806% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -7186.124% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 2032.438% |
| Invivyd, Inc. | -198.47 Million USD | -1035.194% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -2395.943% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -93869.18% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -3082.777% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -32912.278% |
| 2seventy bio, Inc. | 181.71 Million USD | 1339.902% |
| ADMA Biologics, Inc. | 90.06 Million USD | 2601.597% |
| Clene Inc. | 3.34 Million USD | 67557.725% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -24706.36% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -10374.12% |
| GeoVax Labs, Inc. | -6.45 Million USD | -34817.581% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -554.731% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -8565.829% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 1368.159% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -54966.629% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 45143.743% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -43153.753% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -1629.101% |
| Evaxion Biotech A/S | 5.28 Million USD | 42716.881% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -1901.535% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -1616.338% |
| Trevena, Inc. | 2.25 Million USD | 99882.462% |
| Surrozen, Inc. | -32.66 Million USD | -6797.771% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -4274.079% |
| Cingulate Inc. | 3.08 Million USD | 73188.54% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -76613.926% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 31449.492% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -24149.628% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -2740.397% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -1614.001% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -2034.779% |
| Clearmind Medicine Inc. | -3.94 Million USD | -57046.727% |
| Kronos Bio, Inc. | -36.05 Million USD | -6149.204% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 24046.094% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 154619.325% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -4052.698% |
| Statera Biopharma, Inc. | 14.41 Million USD | 15728.639% |
| ImmunityBio, Inc. | 618.22 Million USD | 464.445% |
| Korro Bio, Inc. | -132.94 Million USD | -1594.777% |
| Kineta, Inc. | -4.54 Million USD | -49516.56% |
| BioVie Inc. | -17.73 Million USD | -12606.087% |
| Codexis, Inc. | -43.27 Million USD | -5106.924% |
| Celularity Inc. | 65.19 Million USD | 3556.187% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -70997.76% |
| Celcuity Inc. | 6.78 Million USD | 33314.196% |
| Virax Biolabs Group Limited | -3.36 Million USD | -66857.667% |
| Cibus, Inc. | -8.07 Million USD | -27791.656% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -53177.087% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 49401.707% |
| IN8bio, Inc. | -16.38 Million USD | -13647.562% |
| Kodiak Sciences Inc. | -103.87 Million USD | -2069.038% |
| Annexon, Inc. | -193.75 Million USD | -1062.854% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 6258677.778% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -12775.524% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -64035.724% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 313.71% |
| Eyenovia, Inc. | 1.25 Million USD | 179100.907% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 8474.235% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -69375.424% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -6676.816% |
| Arcellx, Inc. | -296.95 Million USD | -658.723% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -11450.743% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -3726.901% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -10770.304% |
| Moolec Science SA | 117.61 Thousand USD | 1915730.526% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -5767.569% |
| Geron Corporation | 14.76 Million USD | 15363.79% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -5842.001% |
| Royalty Pharma plc | 5.65 Billion USD | 139.819% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -1493.178% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -32135.675% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -41912.814% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -1500.989% |
| Humacyte, Inc. | -22.48 Million USD | -9919.959% |
| Structure Therapeutics Inc. | -124.33 Million USD | -1712.052% |
| 89bio, Inc. | -289.05 Million USD | -679.472% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -8825.949% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -126265.003% |
| Genelux Corporation | -6.89 Million USD | -32558.182% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -7154.219% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 2795.114% |
| Notable Labs, Ltd. | -9.77 Million USD | -22947.136% |
| Liquidia Corporation | -80.17 Million USD | -2710.178% |
| Mustang Bio, Inc. | -3.73 Million USD | -60207.495% |
| Immunovant, Inc. | -635.22 Million USD | -254.69% |
| Quantum-Si incorporated | -118.55 Million USD | -1800.426% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -12727.875% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -54283.007% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 28168.868% |
| Acasti Pharma Inc. | -23 Million USD | -9693.906% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -66812.23% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -13765.693% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -1535.754% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -72198.661% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -10034.437% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -12033.599% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -1230.999% |
| PepGen Inc. | -60.67 Million USD | -3613.677% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -9706.267% |
| United Therapeutics Corporation | -507.7 Million USD | -343.783% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -11680.236% |
| Solid Biosciences Inc. | -47.75 Million USD | -4618.509% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -261252.134% |
| Immuneering Corporation | -54.94 Million USD | -4000.784% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -53500.438% |
| Silo Pharma, Inc. | -3.52 Million USD | -63829.94% |
| Belite Bio, Inc | -87.27 Million USD | -2481.714% |
| XOMA Corporation | -29 Million USD | -7669.269% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -3086.964% |
| Bionomics Limited | 227 Million USD | 1092.507% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -1837.607% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -88849.388% |
| uniQure N.V. | -102.95 Million USD | -2088.505% |
| Cassava Sciences, Inc. | -121.13 Million USD | -1759.966% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -53990.192% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 5601.912% |
| Forte Biosciences, Inc. | -11.96 Million USD | -18736.953% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -72716.495% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 2125654.717% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -69375.424% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 25401.381% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -30281.446% |
| Altimmune, Inc. | -134.48 Million USD | -1575.32% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 1237.55% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -88849.388% |
| Compugen Ltd. | -12.9 Million USD | -17360.384% |
| Peak Bio, Inc. | 10.34 Million USD | 21889.686% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -796044.17% |
| Benitec Biopharma Inc. | -50.58 Million USD | -4354.328% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -2059.413% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 11569.015% |
| Zura Bio Limited | -99.8 Million USD | -2157.467% |
| PolyPid Ltd. | 6.17 Million USD | 36616.823% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 3139.784% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 11569.015% |
| Instil Bio, Inc. | 75.35 Million USD | 3089.846% |
| argenx SE | -2.02 Billion USD | -11.053% |
| Immunome, Inc. | -97.02 Million USD | -2222.077% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -9915.95% |
| Verona Pharma plc | -220.44 Million USD | -922.073% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -3040.499% |
| Shattuck Labs, Inc. | -121.42 Million USD | -1755.554% |
| CervoMed Inc. | -7.79 Million USD | -28812.261% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -1114.609% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -51422.708% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -1610.254% |
| Moolec Science SA | 117.61 Thousand USD | 1915730.526% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -98375.116% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 14271.809% |
| AnaptysBio, Inc. | -18.15 Million USD | -12313.024% |
| Design Therapeutics, Inc. | -18.15 Million USD | -12313.708% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -3101.273% |
| NeurAxis, Inc. | 145.7 Thousand USD | 1546488.469% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 20159.544% |
| Lumos Pharma, Inc. | -28.49 Million USD | -7807.514% |
| Achilles Therapeutics plc | -126.92 Million USD | -1675.147% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -3040.499% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -343499.957% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -10745.802% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 154619.325% |
| Nutriband Inc. | -251.65 Thousand USD | -895201.144% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -17006.431% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -30183.441% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 762.289% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 9592.682% |
| MoonLake Immunotherapeutics | -447.47 Million USD | -403.515% |
| Palisade Bio, Inc. | -12.06 Million USD | -18577.676% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -1505.781% |
| Beam Therapeutics Inc. | -262.72 Million USD | -757.594% |
| Neurogene Inc. | -131.95 Million USD | -1607.467% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 10427.686% |
| AEON Biopharma, Inc. | -4.88 Million USD | -46069.836% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | -497.333% |
| Sesen Bio, Inc. | -112.55 Million USD | -1901.802% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -2156.247% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -95866.212% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -5673.3% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -2605.372% |
| Athira Pharma, Inc. | -88.99 Million USD | -2431.588% |
| Vaccinex, Inc. | -1.28 Million USD | -174829.193% |
| HCW Biologics Inc. | 2.85 Million USD | 78970.968% |
| XOMA Corporation | -29 Million USD | -7669.269% |
| Nektar Therapeutics | 210.24 Million USD | 1171.674% |
| Arvinas, Inc. | -313.8 Million USD | -618.001% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 138931.837% |
| Merus N.V. | -192.88 Million USD | -1068.105% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 3856.086% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -32374.604% |
| Rezolute, Inc. | -68.16 Million USD | -3205.199% |
| Clene Inc. | 3.34 Million USD | 67557.725% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -16985.675% |
| BeyondSpring Inc. | -13.75 Million USD | -16280.138% |
| Synlogic, Inc. | -6.68 Million USD | -33603.635% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 198785.009% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -26547.995% |
| Peak Bio, Inc. | 10.34 Million USD | 21889.686% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -2633.667% |
| Krystal Biotech, Inc. | -350.23 Million USD | -543.309% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 1915.177% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -1233.22% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -71264.752% |
| MannKind Corporation | 143.89 Million USD | 1665.743% |
| Ikena Oncology, Inc. | -109.15 Million USD | -1964.099% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -29659.451% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -6706.912% |
| Gossamer Bio, Inc. | 180.35 Million USD | 1349.252% |
| CohBar, Inc. | -5.93 Million USD | -37890.056% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -7473.914% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 49444.897% |
| Legend Biotech Corporation | -949.39 Million USD | -137.318% |
| Mural Oncology plc | -255.84 Million USD | -780.653% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 7093.91% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -47729.744% |
| Disc Medicine, Inc. | -358.28 Million USD | -528.861% |
| Champions Oncology, Inc. | 4.81 Million USD | 46922.278% |
| REGENXBIO Inc. | 54.76 Million USD | 4213.877% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -837768.854% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -1391.874% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -24900.96% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -2692.519% |
| Vaxart, Inc. | -8.24 Million USD | -27239.983% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -4390.015% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -1671.774% |
| Cellectis S.A. | -43.85 Million USD | -5037.585% |
| Longeveron Inc. | -2.9 Million USD | -77378.955% |
| Repare Therapeutics Inc. | -107.85 Million USD | -1988.939% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 332.666% |
| Inozyme Pharma, Inc. | 12 Million USD | 18869.477% |
| Revolution Medicines, Inc. | -608.2 Million USD | -270.449% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -183077.886% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -749.847% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -1401.338% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -14299.489% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -304371.351% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 76.442% |
| Denali Therapeutics Inc. | -74.86 Million USD | -2909.534% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -18688.727% |
| Veru Inc. | 4.77 Million USD | 47236.038% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -19934.572% |
| Cingulate Inc. | 3.08 Million USD | 73188.54% |
| Passage Bio, Inc. | 4.58 Million USD | 49240.414% |
| Context Therapeutics Inc. | -14.44 Million USD | -15492.491% |
| Exicure, Inc. | 5.84 Million USD | 38620.91% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -878.005% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -5593.93% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 14459.11% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -3730.414% |
| Nuvalent, Inc. | -335.38 Million USD | -571.788% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 130010.323% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -2925.01% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -25244.072% |
| OmniAb, Inc. | 9.2 Million USD | 24582.104% |
| Anew Medical, Inc. | 1.43 Million USD | 157387.473% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 13853.642% |
| Lipocine Inc. | -4.75 Million USD | -47287.62% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -1951.47% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 14892.778% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -4347.557% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 9151.454% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -33423.107% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -3322.741% |
| Ocugen, Inc. | -32.52 Million USD | -6828.102% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -2532.881% |
| Q32 Bio Inc. | -37.94 Million USD | -5837.304% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -358671.975% |
| Alumis Inc. Common Stock | -13.52 Million USD | -16553.766% |
| Equillium, Inc. | -22.39 Million USD | -9962.022% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -8712.14% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -6805.643% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -908714.715% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 1780.882% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 70553.033% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 686094.745% |
| Dominari Holdings Inc. | 195 Thousand USD | 1155529.744% |
| Edesa Biotech, Inc. | -5.26 Million USD | -42678.175% |
| vTv Therapeutics Inc. | -8.91 Million USD | -25167.332% |
| Bio-Techne Corporation | 267.74 Million USD | 941.499% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -13800.228% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -1807.877% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -26712.9% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -17709.564% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -819.181% |
| Nkarta, Inc. | 57.29 Million USD | 4032.159% |
| BioCardia, Inc. | 212 Thousand USD | 1062877.358% |
| Iterum Therapeutics plc | 13.43 Million USD | 16866.543% |